TRIERA - Key Persons
Dr. van der Kuur was the first graduate from University of Guelph with a Specialized Honours in Chemical Physics in 1993, and subsequently completed a doctorate in leadership in 2010. Through his leadership, Zentek is rapidly expanding a high-value IP portfolio through internal research, collaboration, and licensing world-leading technology.
Job Titles:
- Department of Biochemistry
Dr. Miller completed his PhD at the University of Western Ontario studying the molecular virology of DNA viruses, and then conducted postdoctoral research at the Icahn School of Medicine focusing on characterizing the innate and adaptive immune responses to viral infection. His innovative and groundbreaking work has been instrumental in the ongoing development of a ‘universal' influenza virus vaccine.
Job Titles:
- Professor, Department of Biochemistry & Biomedical Sciences
Dr. Li earned a Ph.D. in Biochemistry from Simon Fraser University, and has earned many accolades in his career since: Governor General Academic Gold Medal, Engineering Research Council of Canada Doctoral Prize, and awarded postdoctoral fellow of the Medical Research Council of Canada. Following notable postdoctoral studies at Yale University, his research at McMaster has focused on aptamers and DNAzymes, where he has gained a global reputation as a leader in the field.
Greg Fenton is a seasoned investment professional with a Bay Street career spanning nearly 30 years, including work in various capacities with ever-increasing responsibility in both the Canadian banking and investment management sectors. His experience spans many disciplines: capital markets, investment management, actuarial, pension, insurance, accounting, tax, and risk management.
Job Titles:
- Member of the Advisory Board
John Snisarenko brings with him 35 years of specialty pharmaceutical, medical device and commercialization experience spanning from start-up to large pharmaceutical and biotech companies, including 15 years in the United States in executive positions with Genentech and Shire. He was also a key member of the Genentech/Novartis Global Alliance Partnership for Lucentis in ophthalmology. Currently, he serves as an Independent Director, Board Member, and Advisor to numerous companies.
John holds a B.Sc. in Biochemistry and an MBA in Marketing and International Business from McGill University in Montreal, Canada.